Artemeter plus lumefantrina vs artesunato plus amodiquina
ApprovedCompleted 0 views this week 0 watching⚡ Active
Interest: 43/100
43
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
P. Falciparum Malaria
Conditions
P. Falciparum Malaria
Trial Timeline
Sep 1, 2008 → Dec 1, 2009
NCT ID
NCT04877626About Artemeter plus lumefantrina vs artesunato plus amodiquina
Artemeter plus lumefantrina vs artesunato plus amodiquina is a approved stage product being developed by Sanofi for P. Falciparum Malaria. The current trial status is completed. This product is registered under clinical trial identifier NCT04877626. Target conditions include P. Falciparum Malaria.
What happened to similar drugs?
2 of 4 similar drugs in P. Falciparum Malaria were approved
Approved (2) Terminated (0) Active (2)
Hype Score Breakdown
Clinical
20
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04877626 | Approved | Completed |
Competing Products
20 competing products in P. Falciparum Malaria